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Abstract
Background:  Postoperative pulmonary and shoulder complications are important causes of
postoperative morbidity following thoracotomy. While physiotherapy aims to prevent or minimise
these complications, currently there are no randomised controlled trials to support or refute
effectiveness of physiotherapy in this setting.
Methods/Design:  This single blind randomised controlled trial aims to recruit 184 patients
following lung resection via open thoracotomy. All subjects will receive a preoperative
physiotherapy information booklet and following surgery will be randomly allocated to a Treatment
Group receiving postoperative physiotherapy or a Control Group receiving standard care nursing
and medical interventions but no physiotherapy. The Treatment Group will receive a standardised
daily physiotherapy programme to prevent respiratory and musculoskeletal complications. On
discharge Treatment Group subjects will receive an exercise programme and exercise diary to
complete. The primary outcome measure is the incidence of postoperative pulmonary
complications, which will be determined on a daily basis whilst the patient is in hospital by a blinded
assessor. Secondary outcome measures are the length of postoperative hospital stay, severity of
pain, shoulder function as measured by the self-reported shoulder pain and disability index, and
quality of life measured by the Medical Outcomes Study Short Form 36 v2 New Zealand standard
version. Pain, shoulder function and quality of life will be measured at baseline, on discharge from
hospital, one month and three months postoperatively. Additionally a subgroup of subjects will
have measurement of shoulder range of movement and muscle strength by a blinded assessor.
Discussion: Results from this study will contribute to the increasing volume of evidence regarding
the effectiveness of physiotherapy following major surgery and will guide physiotherapists in their
interventions for patients following thoracotomy.
Trial registration: The study protocol is registered with the Australian and New Zealand Clinical
Trials registry (ANZCTRN12605000201673).
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Background
Physiotherapy interventions have been regularly utilised
in the prevention and treatment of both pulmonary and
musculoskeletal complications following major surgery
since the 1960s. Following thoracotomy, postoperative
pulmonary complications (PPCs) are an important cause
of morbidity, contributing to significant increases in
health care costs, length of intensive care and hospital stay
and patient discomfort [1-5]. In some major surgical
patient groups there has been a steadily accumulating
body of evidence demonstrating that postoperative pro-
phylactic physiotherapy for the prevention of PPCs and
musculoskeletal problems may be unnecessary [6-12].
Whilst physiotherapy for thoracic surgical patients contin-
ues to be strongly advocated, to date there have been no
randomised controlled trials supporting its effectiveness.
Evidence from a recent cross sectional study with histori-
cal controls in patients following lung resection suggests
that physiotherapy may reduce length of hospital stay and
incidence of atelectasis (with a subsequent reduction in
hospital costs) but appears to have no influence over the
incidence of pneumonia and overall morbidity [13].
Other research has demonstrated that adding various
adjuncts (such as incentive spirometry) to usual care phys-
iotherapy treatment programmes makes no significant
difference to outcome, however to date there have been
no randomised controlled trials including a no treatment
group [14-17]. It remains unknown whether prophylactic
respiratory physiotherapy, as part of inpatient postopera-
tive recovery, is necessary following pulmonary resection
and clarification of the role and efficacy of these interven-
tions is overdue.
Thoracotomy may also lead to chronic pain and long term
restriction of shoulder function and physiotherapy and
early mobilisation are commonly recommended and
implemented to prevent these problems [18,19]. Whilst
shoulder range of movement, strength and function has
been extensively examined in this patient group [20-24]
the role of a postoperative physiotherapy exercise pro-
gramme in minimising this dysfunction has not been
investigated. Significant correlation between upper limb
morbidity and poorer quality of life has been reported in
patients in other surgical groups [25]. A study to evaluate
the effectiveness of a shoulder and thoracic cage exercise
programme following thoracotomy should further
develop an understanding of both short and long term
shoulder morbidity in this patient group.
The Physiotherapy Management of the patient undergo-
ing Thoracic Surgery study (PMoTS) was designed as there
are no published RCTs which address these outcomes.
Aims and Hypotheses
Thus the primary aims of the study are to:
1. Compare the incidence of PPCs between groups
2. Compare the postoperative length of hospital stay
(LOS) between groups
The secondary aims are to:
3. Compare LOS in those subjects who develop PPCs and
those who do not.
4. Compare the recovery of shoulder function, shoulder
range of motion (ROM), and shoulder muscle strength
(MMS) between groups
5. Compare the health related quality of life (HRQoL)
between groups
The study hypothesis for the primary aims is:
H1. Routine postoperative prophylactic physiotherapy
will significantly reduce the incidence of PPCs and LOS
compared to no postoperative physiotherapy following
open thoracotomy.
The hypothesis for the secondary aim is:
H2. A postoperative exercise programme will significantly
improve the recovery of shoulder ROM, muscle strength
and function following open thoracotomy.
Methods and Design
Study design
The PMoTS study is a single blinded randomised control-
led trial of patients undergoing elective pulmonary resec-
tion via open thoracotomy in one thoracic surgical unit in
New Zealand. The study aims to investigate the effective-
ness of physiotherapy treatments following surgical
removal of part or whole of one lung.
Subjects
Inclusion/exclusion criteria
To be eligible for enrolment subjects must be adults
admitted to Auckland City Hospital, New Zealand to
undergo elective lung resection via open thoracotomy.
They must understand written and spoken English and
give informed written consent. Subjects will be excluded if
they are unable or unwilling to comply with treatment,
have tumour invasion into the chest wall or brachial
plexus, present with a PPC prior to randomisation on
postoperative day one, remain ventilated for longer than
24 hours following surgery or have received physiother-
apy for shoulder problems or respiratory problems within
two weeks prior to admission for surgery. Subjects with
postoperative neurological or mobility complications
requiring comprehensive physiotherapy input to progressJournal of Cardiothoracic Surgery 2008, 3:48 http://www.cardiothoracicsurgery.org/content/3/1/48
Page 3 of 10
(page number not for citation purposes)
towards discharge (defined as being more than two phys-
iotherapy interventions), will be provided with the physi-
otherapy as required, remain in the group to which they
were allocated and analysed using intention to treat prin-
ciples. Subjects, who live within a 60 km radius of Auck-
land Hospital and can attend outpatient appointments,
will form a subgroup that, in addition to all other meas-
ures, will attend for follow up shoulder ROM and muscle
strength measures.
Sample size
Sample size was calculated for the primary outcome meas-
ure of PPC with a type I error rate of .05 and a type II error
rate of 0.20 (80% power). Estimates of the incidence of
PPCs vary throughout the literature dependent upon cri-
teria used for diagnosis but best estimates suggest a PPC
rate (after thoracotomy and amenable to physiotherapy
interventions) of between 10–25% occurs in this popula-
tion with routine physiotherapy care [4,14], Assuming a
PPC rate of 20% in the Control Group and 5% in the
Treatment Group (thus a 15% difference in PPCs), 84 sub-
jects in each group are required. Allowing for an estimated
loss to follow up rate of 9% (based on similar studies) a
sample size of 184 subjects (92 per group) is necessary to
demonstrate sufficient power for the primary outcome.
Because there are no randomised trials that include a con-
trol group on which to accurately base this sample size
calculation, an interim analysis will be undertaken when
total n = 80.
Ethics and study registration
Ethical permission for the study was granted from North-
ern X Regional Ethics Committee in October 2005. The
study protocol is registered with the Australian and New
Zealand clinical trials registry
(ANZCTRN12605000201673). The flow of subjects
through the study follows the CONSORT (Consolidated
Standards of Reporting Trials) recommendations (see Fig-
ure 1).
Procedures
Recruitment and randomisation
Subjects eligible to take part are screened from the tho-
racic surgical operating list by the study investigators (JR
& KN) on admission to hospital. If eligible to take part the
study investigators approach the subject to explain the
study and gain informed consent. It is explained that they
may withdraw from the study at any time without jeop-
ardising their future care. On day one postoperatively,
prior to any physiotherapy interventions and following
extubation, subjects are given a consecutive study number
and randomly allocated to the Treatment Group or Con-
trol Group by an independent physiotherapist. The ward
physiotherapist is then told of the group allocation which
is recorded and the envelope stored. Group allocation is
assigned using a computer generated random allocation
(from http://www.randomization.com) and individual
group assignment is kept in sealed opaque envelopes.
In the event of more than one thoracic surgical procedure
per day randomisation is performed according to order of
admission onto the postoperative intensive care/surgical
ward. To avoid influencing postoperative regimens, sub-
jects taking part in the research trial are, where possible,
allocated to separate rooms during their hospital stay.
In the subgroup who meet the inclusion criteria for shoul-
der ROM and muscle testing, a computer generated ran-
domised order for performing the ROM and muscle
strength measures is determined before preoperative
measures and adhered to throughout the study. The ran-
domisation order is generated from http://www.randomi
zation.com.
Interventions
a. Preoperative education
After consent all subjects have preoperative demographic
data recorded in order to compare baseline measures
between groups (see Table 1), and are given a physiother-
apy written information sheet by a study investigator. This
broadly explains the need for postoperative breathing and
coughing exercises, early ambulation, and shoulder
mobility exercises. It outlines breathing exercises, huffing/
coughing and the importance and progression of ambula-
tion postoperatively. It gives general advice about shoul-
der and arm use in the postoperative period. No other
form of preoperative physiotherapy education and treat-
ment is provided to subjects in either group.
b. Postoperative treatment
Both Treatment and Control Group subjects will receive
standard nursing and medical care according to the clini-
cal pathway in use at the unit where the research is being
undertaken.
Subjects in the Treatment Group will receive postopera-
tive physiotherapy from the attending ward physiothera-
pist as per a written protocol on a daily basis until
discharge. This includes a minimum  predetermined
amount of: deep breathing and coughing exercises, assist-
ance with ambulation, and a progressive shoulder and
thoracic cage mobility exercise programme (see Figure 2).
Subjects will be encouraged by the attending physiothera-
pist to practice the exercises outside physiotherapy treat-
ment times but this practice will not be quantitatively
measured. Upon discharge from hospital Treatment
Group subjects will receive a discharge exercise and advice
sheet with an exercise diary explained by the attending
ward physiotherapist.Journal of Cardiothoracic Surgery 2008, 3:48 http://www.cardiothoracicsurgery.org/content/3/1/48
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Trial protocol Figure 1
Trial protocol.
Screened for recruitment 
(following admission to hospital) 
Allocated to Physiotherapy 
Treatment Group 
Allocated to Control Group
Ineligible:
 Failed inclusion criteria 
 Met exclusion criteria 
 Refused consent 
Daily hospital assessments, 
Hospital discharge, one month and three month 
assessments 
Surgery
Randomised
Ineligible:
 Met exclusion criteria 
Lost to follow 
up (reasons)  Lost to follow 
up (reasons) 
Consent, baseline measures
Analysed
Control Group subjects will receive no postoperative
physiotherapy. They may be verbally encouraged by
attending nursing staff to practice the exercises outlined
on their preoperative physiotherapy information sheet
throughout their postoperative stay.
Outcome measurement
Outcome measures, instruments used and timeframes for
measurement are summarised in Table 2.
1. PPC
Will be diagnosed on a daily basis until hospital discharge
using the diagnostic tool shown in Table 3. The data will
be collected by an attending physiotherapist and phoned
to a blinded assessor who determines the diagnosis of a
PPC.
2. Length of Stay (LOS)
Length (number of days) of postoperative stay will be
measured from data held on the hospital database.
3. Shoulder function
Will be measured using the Shoulder Pain and Disability
Index (SPADI) preoperatively, on discharge from hospi-
tal, one month and three months postoperatively. This is
a self reported shoulder specific index developed by
Roach et al. (1991) [26] which consists of 13 items in two
subscales: pain (5 items) and disability (8 items). Each
item is measured on an 11 point Likert scale where 0 = "no
pain/no difficulty" and 11 = "worst imaginable pain/so
difficult it required help" on each subscale respectively.
The SPADI is scored by adding then averaging the two
subscales to determine a score out of 100. A higher score
means greater pain/disability. The SPADI has been dem-Journal of Cardiothoracic Surgery 2008, 3:48 http://www.cardiothoracicsurgery.org/content/3/1/48
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Table 1: Demographic Data
▪ Age
▪ Ethnicity
▪ Sex
▪ Smoking history & pack year history
▪ Body mass index (BMI)
▪ American Society of Anaesthesiologists score (ASA)
▪ Hand dominance
▪ History and symptoms of chronic lung disease
▪ Relevant past medical history
▪ Percutaneous oxygen saturation (SpO2)
▪ Pulmonary function tests
 Forced Expiratory Volume in 1 second (FEV1)
 Forced Vital Capacity (FVC)
 FEV1/FVC
▪ Date of surgery
▪ Surgeon
▪ Surgical procedure
▪ Duration of anaesthesia
▪ Incision site/type of thoracotomy (muscle sparing, postero-lateral, antero-lateral, axillary)
▪ Rib resections
▪ Number of chest drains in situ, length of time on suction (number of days) and length of time in situ (number of days) postoperatively
▪ Postoperative analgesia and method of administration
▪ Relevant past medical history of shoulder or upper back/neck problems and management
▪ Presence of seroma at wound site (Y/N)
▪ Time to first sit out of bed (number of hours postoperatively)
▪ Time to first mobilisation > 10 metres or equivalent walk on spot if chest drains remain on suction (number of days postoperatively)
▪ Reason for increased length of stay
▪ Physiotherapy interventions administered (total number of sessions, cumulative time and type of intervention)
▪ Return to the intensive care unit and operating theatre
▪ Postoperative chemotherapy or radiotherapy
onstrated to detect change in subject's status over time,
have good test-retest reliability, internal consistency and
good criterion and construct validity although not within
the thoracic surgical population [26-28].
4. Shoulder ROM
In a subgroup of patients living within a 60 km radius of
Auckland Hospital, active ROM will be measured preop-
eratively, on discharge from hospital, one month and
three months postoperatively by a blinded assessor using
digital inclinometry via a Plurimeter-V inclinometer.
ROM will be measured in those muscle groups which are
divided during surgery thus potentially affecting range of
movement. The measures are:
a. Total shoulder flexion (the movement includes
scapular motion)
b. Total shoulder elevation through abduction (the
movement includes scapular motion)
c. Glenohumeral external rotation
All ROM measures (except external rotation) are taken
with the subject fully upright in a standardised chair with
the opposite forearm resting on a fixed table to eliminate
trunk movement. Sitting has been chosen as the starting
position for most measures due to the possibility of sub-
jects with respiratory disorders being unable to tolerate
supine lying. The position of the inclinometer is estab-
lished by measurement from a clear surface marking (e.g.
1 cm above lateral epicondyle).
▪ Shoulder flexion is measured with the arm at the
side, elbow extended, shoulder in neutral rotation
with palm facing the thigh and thumb facing forwards.
The subject actively flexes the arm with the thumb
leading throughout, maintaining elbow extension.
▪ Shoulder elevation is measured with the arm at the
side, elbow extended, arm in external rotation with the
palm facing forward. The subject actively elevates the
arm leading with the thumb maintaining elbow exten-
sion.
▪ Shoulder external rotation is measured in supine
lying (on a standardised bed) with the arm at side,Journal of Cardiothoracic Surgery 2008, 3:48 http://www.cardiothoracicsurgery.org/content/3/1/48
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Example of minimum physiotherapy intervention programme Figure 2
Example of minimum physiotherapy intervention programme.
Postoperative Day Two 
NB. These interventions comprise the MINIMUM level of care to be provided and supervised by
the physiotherapist to ALL TREATMENT GROUP patients during the period of the trial. Attending
physiotherapists have complete discretion to add further interventions to these should they
deem this appropriate to individual patient care. All treatment should be documented on the
physiotherapy intervention data collection sheet. 
TWICE daily treatment comprising of the following exercises on BOTH occasions: 
x In long sitting/half lying in bed or sitting out of bed 
o 5 sets of 4 (or equivalent i.e. 20 breaths) deep breaths incorporating
sustained maximal inspiration (3 seconds) on each breath. 
o Forced Expiratory Technique or cough x 2 
x Ambulate with or without assistance over 15 metres or equivalent on spot
(approximately 1.5 minutes) unless unsafe to do so 
x In sitting or standing, active or active assisted shoulder ROM exercises within
pain limits on thoracotomy side incorporating (as per preoperative info sheet):
This must include exercises 1, 2, 3 and 4 as below: 
1 Elevation through flexion x 5 (using physio or self assist) 
2 Both hands to back of neck – spread elbows out as far as possible and bring
together in front of face x 5 (external rotation with pro/retraction) 
3 Elevation through abduction x 5 
4 Operated side hand to opposite buttock x 5 (internal rotation) 
1b. 2. 3 4 G
humerus supported by the bed, elbow flexed to 90°,
forearm in the mid prone position, hand in fisted
position, pointing towards the ceiling. The subject
actively externally rotates the arm maintaining the
elbow on the bed and leading with the dorsum of the
hand.
For all movements care is taken to avoid trunk assisted
movements. On each occasion the arm is returned to 0°
and each movement is repeated twice after one practice
measure. These measures, where possible, follow a stand-
ardised protocol that has been shown to have acceptable
intra and interrater reliability for use within a randomised
controlled trial [29]. As well as recording ROM subjects
report maximum pain during each movement on a 0 – 10
verbal rating scale. The maximum reading for pain for
each movement is recorded.
5. Isometric muscle strength
In a subgroup of patients living within a 60 km radius of
Auckland Hospital, muscle strength will be measured pre-
operatively, one month and three months postoperatively
by a blinded assessor using a handheld manual muscle
tester (Lafayette instruments) which has been shown to
have moderate to high interrater and intrarater reliability
[30]. Measurements will be made of those of muscle
groups that have been divided during surgery and thus
may affect muscle strength. The measures are:
a. Shoulder flexion
b. Shoulder abduction
c. Shoulder internal rotation
d. Shoulder extensionJournal of Cardiothoracic Surgery 2008, 3:48 http://www.cardiothoracicsurgery.org/content/3/1/48
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Table 2: Summary of outcome measurements
Primary Outcomes Measurement instrument Time point
PPC 8 point item score (see Table 3) Postop daily to discharge
Secondary Outcomes Measurement instrument Time point
LOS Retrospective from patient information 
database
At discharge
SPADI 13 items scored on 11 point Likert scale Preop, at discharge, 1 month postop, 3 months 
postop
ROM of shoulder flexion, elevation through 
abduction and external rotation (subgroup)
Plurimeter – V inclinometer Preop, at discharge, 1 month postop, 3 months 
postop
MMS of shoulder abduction, flexion and 
internal rotation (subgroup)
Hand held dynamometer 
(Lafayette Instruments)
Preop, 1 month postop, 3 months postop
HRQoL Short Form 36 v2 (NZ) Preoperative, 1 month postop, 3 months 
postop
Pain Body charts and verbal rating scale (end 
descriptors 0 = no pain and 10 = worst pain 
possible)
Preop, at discharge, 1 month postop, 3 months 
postop
Key : HRQoL – Health related quality of life, LOS – length of postoperative hospital stay, MMS – muscle strength, NZ – New Zealand, Postop – 
postoperative, PPC – postoperative pulmonary complication, Preop – preoperative, ROM – range of movement, SPADI – shoulder pain and 
disability index.
All measures are taken in the same position as described
for ROM testing with the position of the dynamometer
established in the same way using the easily identifiable
surface markings of 1 cm above the elbow crease (for flex-
ion), 1 cm above the lateral epicondyle (for abduction), 1
cm above the olecranon (for extension) or the skin crease
(usually middle) between the radial styloid process and
the head of the ulna (for internal rotation). The starting
position is with the arm at the side with one gripped fist
width between the distal end of the humerus and chest
wall, the elbow flexed to 90° and the forearm in the mid
prone position. This position was chosen due to the
potential for subjects to be unable to commence muscle
strength measures in 90° or 45° glenohumeral abduction
as recommended by some authors [31,32]. Resistance is
applied against the direction of shoulder movement for
three to five seconds. The "make" (rather than "break")
technique is used requiring the examiner to resist a maxi-
mal voluntary contraction by the subject which is essen-
tially an isometric contraction and has been shown to
have high interrater and intrarater reliability even in inex-
perienced examiners [33].
Standardised instructions and verbal encouragement is
given and, after one practice contraction, each movement
is measured three times with one minute between meas-
ures. Subjects report maximum pain during each move-
ment on a 0 – 10 verbal rating scale. In keeping with other
authors the maximum intensity of pain for each move-
ment will be recorded [33-35].
Demographic and background information
Table 1 gives subject and operative data that will be col-
lected and used to compare characteristics that could
influence the outcome of the study. These data will be col-
lected by the study investigators from subjects' medical
records. In addition, records of any postoperative radio-
therapy, chemotherapy and information regarding any
additional shoulder treatments from health care profes-
sionals will be sought.
Data analysis
Analyses will be conducted using an intention to treat
principle for all randomised subjects. Demographic data
will be analysed using descriptive statistics, Chi squared
and Independent t tests or parametric equivalents.
A Chi squared test will be used to determine if there is any
significant difference in the incidence of PPC between
groups. LOS will be tested for normality of data. If nor-
mally distributed an Independent t test will be used to cal-
culate the differences in mean LOS between groups and in
differences in LOS in those subjects who do and do not
develop PPCs. Data will be presented as mean differences
with 95% confidence intervals. If data are not normally
distributed a non parametric Mann Whitney U test will be
used. The absolute risk reduction and number needed to
treat will also be calculated for the primary outcome of
PPC. Further between group comparisons for repeated
measures of interval data (such as shoulder ROM, shoul-
der muscle strength, ADL and HRQoL) will be made using
repeat measures ANOVA. Significant results will be ana-Journal of Cardiothoracic Surgery 2008, 3:48 http://www.cardiothoracicsurgery.org/content/3/1/48
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Table 3: Postoperative pulmonary complication diagnostic tool
During this trial the following criteria will be used to diagnose PPCs. Patients must be assessed before 11 am daily.
PPCs
For the purposes of this study PPC will be diagnosed by presence of 4 or more of the following:
1. Chest radiograph report of atelectasis/consolidation. In the event of no CXR being taken, the CXR report from the previous postoperative day 
will be used. If neither are available a not available will be reported (n/a). If a CXR report is not available but a CXR has been taken a ward medical 
officer will be asked to report on this should this be the defining criteria for PPC.
2. An otherwise unexplained WCC of >11.2 × 109/L or administration of respiratory antibiotics postoperatively (in addition to those administered 
routinely postoperatively). In the event of no WCC being taken, the WCC report from the previous postoperative day will be used. If none of 
these are available a n/a will be reported
3. Fever as seen by raised oral temperature >38°C with no focus outside of the lungs. The highest temperature within the previous 24 hours will be 
reported.
4. Positive signs of infection on sputum microbiology.
5. Production of purulent (yellow or green) sputum differing from preoperative status
6. SpO2 < 90% on room air (see measurement protocol below).
7. Diagnosis of pneumonia/chest infection by attending physician.
8. Re-admission to the ITU/HDU with problems which are respiratory in origin or a prolonged stay on the ITU/HDU (over 36 hours) with 
problems which are respiratory in origin.
Sp02 measurement
All SpO2 measurements will be taken in the morning prior to physiotherapy treatment. Prior to measurement of SpO2:
▪ The patient will be positioned in upright sitting (or long sitting if unable to be out of bed).
▪ O2 therapy will be withdrawn for a period of 5 minutes & SpO2 will be monitored but not recorded during this time. NB if patient on room air 
allow monitor to stabilise for 1 minute prior to reading.
▪ Measurement will be by designated pulse oximeter via a finger probe.
▪ After 5 minutes the SpO2 will be measured by reapplying the finger sensor to the index finger of one hand for 30 seconds.
▪ The lowest SpO2 during the 30 second measuring period will be recorded.
▪ If a patient's SpO2 drops below 88% at any stage of the measures they will be immediately returned to supplemental O2 as prescribed and 
measures abandoned. This will be noted and the value recorded.
▪ If the SpO2 drops below 90% (i.e. 89% or below) this will be noted as achieving as one of the criteria for PPC.
▪ Only patients with an SpO2 of 89% or below will not be taken off oxygen for SpO2 monitoring purposes (i.e. these patients will have already 
achieved criteria for PPC without removal from O2).
▪ If the physiotherapists notes the hands to be cool, peripheral shutdown, poor pulsatile flow on the SpO2 monitor or a dampened trace this will be 
recorded as being unreliable (N). A reliable trace will be recorded as (Y).
Key: CXR – Chest X Ray, SpO2 – Percutaneous oxygen saturation, PPC – postoperative pulmonary complication, WCC – white cell count, HDU – 
high dependency unit, ICU – intensive care unit.
lysed using post hoc tests such as the Scheffe F test. The
alpha level for all statistical analyses will be set at 0.05.
Discussion
This study uses a single blind randomised controlled
design to investigate the efficacy of physiotherapy inter-
ventions in the prevention of complications following
pulmonary resection via open thoracotomy. The benefits
of physiotherapy for these patients have not been estab-
lished despite being widely recommended as an integral
part of standardised postoperative care. To our knowledge
this will be the first randomised controlled trial using a
Control Group with no physiotherapy to study the effi-
cacy of physiotherapy interventions in preventing pulmo-
nary and shoulder complications in this population.
The role of prophylactic physiotherapy, particularly the
value of deep breathing exercises, following other types of
major surgery has been recently challenged as a result of
evidence from RCTs [36,37]. Prior to the current study
being initiated, we determined, using a postal survey, that
the majority of physiotherapists continue to prophylacti-
cally treat patients after open thoracotomy [19]. Most
commonly deep breathing and airway clearance manoeu-
vres, early ambulation and shoulder exercises were used
for patients following thoracic surgery [19]. Whether this
level of intervention is necessary in this patient group is
currently unknown. Given the findings of the survey
which determined commonality in practices across physi-
otherapy providers, we have chosen to use standardised
minimum physiotherapy interventions (see example in
Figure 2) rather than utilising a pragmatic design where
therapists would be free to choose their own interven-
tions. This will enable both reproducibility and consist-
ency. Delivery of the programme is by the attending ward
physiotherapist whose identity will vary according to
workload allocations thus increasing the external validity
of the study. Deviations from the standardised protocol
will be recorded.Journal of Cardiothoracic Surgery 2008, 3:48 http://www.cardiothoracicsurgery.org/content/3/1/48
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For all subjects, the self reported measures of shoulder
function will provide clinically relevant measures of
shoulder recovery following surgery. Studies have shown
ROM impairment and functional status to be significantly
associated [38,39] and therefore any subject not achieving
recovery of shoulder function scores within 20 per cent of
preoperative status will be offered outpatient follow up
physiotherapy as necessary. As subjects undergoing pul-
monary resection in our surgical unit are drawn from a
wide geographical area, follow up measures of shoulder
ROM and MMS are not feasible for all patients. Thus we
determined that patients living within 60 kilometres of
the unit who were able to attend outpatient appointments
will form a subgroup who will undergo ROM and muscle
strength testing as additional measures.
It is anticipated that data collection will be completed by
late 2008 and that this study will contribute to the increas-
ing evidence base into the effects of physiotherapy inter-
ventions following major surgery.
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